Cargando…
Complexin-1 and Foxp1 Expression Changes Are Novel Brain Effects of Alpha-Synuclein Pathology
As the second most frequent neurodegenerative disorder of the aging population, Parkinson’s disease (PD) is characterized by progressive deficits in spontaneous movement, atrophy of dopaminergic midbrain neurons and aggregation of the protein alpha-synuclein (SNCA). To elucidate molecular events bef...
Autores principales: | Gispert, Suzana, Kurz, Alexander, Brehm, Nadine, Rau, Katrin, Walter, Michael, Riess, Olaf, Auburger, Georg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510914/ https://www.ncbi.nlm.nih.gov/pubmed/25112678 http://dx.doi.org/10.1007/s12035-014-8844-0 |
Ejemplares similares
-
Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress
por: Kurz, Alexander, et al.
Publicado: (2010) -
Methyl-Arginine Profile of Brain from Aged PINK1-KO+A53T-SNCA Mice Suggests Altered Mitochondrial Biogenesis
por: Auburger, Georg, et al.
Publicado: (2016) -
A53T-alpha-synuclein-overexpression in the mouse nigrostriatal pathway leads to early increase of 14-3-3 epsilon and late increase of GFAP
por: Kurz, Alexander, et al.
Publicado: (2011) -
Striatal Dopamine Transmission Is Subtly Modified in Human A53Tα-Synuclein Overexpressing Mice
por: Platt, Nicola J., et al.
Publicado: (2012) -
Potentiation of neurotoxicity in double-mutant mice with Pink1 ablation and A53T-SNCA overexpression
por: Gispert, Suzana, et al.
Publicado: (2015)